Key Takeaways
- Prior authorization remains the single largest administrative burden in behavioral health: physicians complete an average of 39 PA requests per week, and 95 percent of physicians in the 2025 AMA Prior Authorization Physician Survey said prior auth delays access to necessary care.
- Behavioral health and SUD treatment absorb a disproportionate share of the friction: a Health Affairs Scholar study found 42 percent of patients reporting negative effects from prior authorization were receiving psychiatric, behavioral health, or substance use care, compared with 15 percent in plastic surgery.
- CMS-0057-F took effect January 1, 2026, but applies narrowly: Medicare Advantage, Medicaid managed care, CHIP, and federal exchange plans must now decide standard requests within 7 days and urgent requests within 72 hours, but employer-sponsored ERISA plans are excluded from the new timelines.
- Federal mental health parity enforcement is in limbo: the Departments of Labor, HHS, and Treasury paused enforcement of the 2024 MHPAEA final rule in May 2025 pending litigation, leaving state regulators to fill the federal gap on behavioral health authorization practices.
On May 13, 2026, the American Medical Association released its 2025 Prior Authorization Physician Survey, a poll of 1,000 practicing physicians taken six months after roughly 60 insurers pledged to streamline the process. Ninety-five percent said prior authorization delays access to necessary care. Seventy-nine percent said patients abandon treatment because of authorization disputes. More than one in four said prior authorization has led to a serious adverse event, including hospitalization, permanent impairment, or death.
What is new in 2026 is the regulatory environment around prior authorization. The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) took effect January 1, requiring shorter decision timelines, specific clinical denial reasons, and public aggregate authorization metrics. Sixty insurers signed a separate voluntary pledge in June 2025 to cut authorization requirements and expand qualified clinical review.
Behavioral health providers say the reforms, real as they are, do not yet address the practices that affect their patients most. One federal lever that might have closed the gap, the strengthened 2024 mental health parity rule, has been paused. The result is a 2026 in which prior authorization is theoretically more transparent and faster, but still the largest administrative pressure point in behavioral health revenue cycle operations.
Why behavioral health absorbs a disproportionate share of the prior authorization burden
Across medicine, the cost of prior authorization is measurable. The AMA’s 2024 survey found physicians and staff complete an average of 39 PA requests per physician per week, consuming roughly 13 hours weekly. CAQH index data places the cost of a single request at about 24 minutes. Forty percent of practices have hired staff to work exclusively on prior authorization, and cumulative revenue loss from PA inefficiencies has been estimated at $23 to $31 billion annually.
The burden is not evenly distributed. A 2024 Health Affairs Scholar study found the negative impact of prior authorization is highest for psychiatry, behavioral health, substance use treatment, and mental-health-related rehabilitation: 42 percent of those patients reported it impeded their ability to seek treatment, against 15 percent in plastic surgery. A Johns Hopkins literature review in The American Journal of Medicine (September 2025) identified 11 behavioral health studies linking prior authorization to treatment interruptions, higher relapse rates, and worse outcomes. The administrative pressure compounds reimbursement pressure that Acuity has identified as a primary driver of behavioral health clinician burnout.
Several structural features of behavioral health billing make the friction worse. Authorization cycles for higher levels of care are short: residential SUD treatment, partial hospitalization, intensive outpatient, and inpatient psychiatric admissions are typically authorized in 7-day to 14-day increments, requiring concurrent review at every step. Reviewers trained on medical models expect clean clinical thresholds; behavioral health diagnoses rarely provide them. The American Society of Addiction Medicine’s six-dimension criteria, used by most major commercial payers, require providers to argue medical necessity at each dimension at each review. Documentation scrutiny is now tracked at the code level, as OIG audit findings on ABA codes 97153, 97155, and 97156 illustrate.
Provider portals add a workflow tax. Even within a single insurer brand, behavioral health authorizations may route through a different subsidiary than medical authorizations: Anthem behavioral health frequently runs through Carelon, and UnitedHealthcare behavioral health runs through Optum Provider Express. Front-desk staff handling three patients on the same insurance card may need to submit through three different portals with different deadlines and format requirements.
What CMS-0057-F actually changes for Medicare Advantage and Medicaid, and what it leaves untouched in ERISA plans
The CMS Interoperability and Prior Authorization Final Rule represents the most significant federal change in more than a decade. As of January 1, 2026, Medicare Advantage organizations, state Medicaid and CHIP fee-for-service programs, Medicaid managed care plans, CHIP managed care entities, and qualified health plan issuers on the federally facilitated exchanges must decide standard prior authorization requests within 7 calendar days and expedited requests within 72 hours. Before the rule, many payers took up to 14 days. Denials must now include specific clinical reasons, identifying the criteria set used (InterQual, MCG, ASAM, Milliman, or proprietary) and which documentation requirements were not met.
Aggregate transparency is the second major shift. Payers must post approval rates, denial rates, appeal overturn rates, and average decision turnaround times annually, with the first reports (covering calendar year 2025) due March 31, 2026. The API requirements that will eventually allow direct EHR-to-payer prior authorization submission take effect January 1, 2027.
For behavioral health providers, the rule’s value depends on whether their payer mix is captured by it. Medicaid managed care (which covers nearly one-third of adults with mental health disorders and one-fifth of adults with substance use disorders), Medicare Advantage, and exchange-based qualified health plans are in scope. Employer-sponsored ERISA plans, the largest segment of commercial coverage, are not. For practices whose payer mix is heavily commercial-ERISA, the new timelines do not apply.
The June 2025 voluntary insurer pledge was meant to fill that gap. About 60 insurers (including UnitedHealthcare, Aetna, Cigna, Humana, Blue Cross Blue Shield Association, and Kaiser Permanente) committed to cut services subject to prior authorization, ensure that denials are reviewed by appropriately qualified clinicians, and accelerate electronic processing. The AMA’s May 2026 survey suggests provider experience has not caught up. Only 33 percent of physicians believe the pledge will produce meaningful change, only 24 percent report consistent qualified-clinician review of denials, and just 16 percent of peer-to-peer reviewers say the health plan representative has the appropriate qualifications. UnitedHealthcare led the burden ranking, with 75 percent of surveyed physicians rating its administrative burden as high or extremely high.
Insurers point to incremental progress. AHIP and BCBSA reported pledge signers reduced prior authorization requirements by 11 percent in the following year (roughly 6.5 million fewer requests), with a 15 percent reduction inside Medicare Advantage. UnitedHealthcare announced in May 2026 it would eliminate prior authorization for 30 percent of services that had previously required it. Whether those reductions reach the higher levels of behavioral health care where authorization friction is most acute is the open question. Acuity has covered related operational pressure on ABA, including Indiana’s credential-tiered Medicaid ABA phasedown and the OIG Medicaid ABA audits driving a coming wave of recoupments.
Mental Health Parity enforcement retreats, leaving state regulators to police behavioral health authorization
The strongest federal lever that might have aligned behavioral health authorization with medical and surgical standards is the Mental Health Parity and Addiction Equity Act, particularly the 2024 final rule strengthening its non-quantitative treatment limitation (NQTL) comparative analysis requirements. On May 15, 2025, the Departments of Labor, HHS, and Treasury issued a non-enforcement statement covering portions of the 2024 rule beyond the 2013 baseline, pending an ERISA Industry Committee lawsuit plus 18 months. In April 2026, the administration signaled it intends to propose a new parity rule replacing the 2024 version.
The non-enforcement does not eliminate MHPAEA. The 2013 rule remains in effect, and the Consolidated Appropriations Act of 2021 still requires plans to prepare written NQTL comparative analyses on demand. Several states have moved to fill the federal gap. Washington enacted legislation requiring insurers to comply with the 2024 federal rule. Oregon’s 2025 parity report identified disparities in claims denials, provider reimbursement, and prior authorization documentation. West Virginia requested insurer data on denied claims and authorization outcomes. Georgia announced $25 million in mental health parity fines in January 2026, though three months later none had been collected, one of the state’s parity bills had died in the Senate, and another awaited the governor’s signature.
For behavioral health providers, the strongest parity arguments in 2026 are state-by-state. When a payer’s medical necessity criteria appear more restrictive for an outpatient SUD counseling authorization than for outpatient physical therapy, the disparity remains a parity violation and is still appealable. But the strength of the argument depends on which state regulator has jurisdiction and whether the plan is a fully insured product subject to state insurance law or a self-funded ERISA plan.
Provider advocacy organizations have grown louder. The National Council for Mental Wellbeing, representing more than 3,200 mental health and substance use treatment organizations, has pressed Congress to fund implementation of the SUPPORT Act (signed December 1, 2025). The Partnership to End Addiction has documented how prior authorization for SUD treatment, particularly for medications for opioid use disorder, delays initiation of care at the moment when delay is most dangerous. Ten states limit state-regulated commercial plans from imposing prior authorization on SUD services; five limit Medicaid’s use of prior authorization for the same. The stakes are not abstract: Kentucky’s largest SUD provider collapsed from 30 facilities to “desperate straits”, a pattern authorization friction is likely to accelerate.
Whether the cumulative effect produces meaningful relief in 2026 will hinge on how aggressively state regulators use the newly mandated public reporting data, whether insurers operationalize pledged reforms beyond physical health, and whether federal parity enforcement returns. For now, behavioral health providers work in a system where the rules have changed, data is partially visible for the first time, and pressure on care delays has not yet eased.
Frequently Asked Questions
What is the CMS Interoperability and Prior Authorization Final Rule?
Finalized in January 2024 and effective January 1, 2026, CMS-0057-F requires Medicare Advantage organizations, state Medicaid and CHIP fee-for-service programs, Medicaid managed care plans, CHIP managed care entities, and qualified health plan issuers on the federally facilitated exchanges to issue standard prior authorization decisions within 7 calendar days and expedited decisions within 72 hours. Denials must include specific clinical reasons. Beginning March 31, 2026, payers must publish aggregate prior authorization metrics annually. The FHIR-based prior authorization API requirement takes effect January 1, 2027.
Why is prior authorization a bigger problem in behavioral health than in other specialties?
Behavioral health treatment is individualized, and clinical progress does not produce the clean quantitative thresholds reviewers trained on medical models often expect. Authorization cycles for higher levels of behavioral health care (residential, PHP, IOP, inpatient psychiatric) are shorter than in most other specialties, often 7 to 14 days, requiring concurrent review at every step. A 2024 Health Affairs Scholar study found that 42 percent of patients reporting negative effects from prior authorization were receiving psychiatric, behavioral health, or substance use care, the highest rate across measured specialties.
What did the 2025 AMA Prior Authorization Physician Survey find?
Released May 13, 2026, the survey of 1,000 practicing physicians found that 95 percent reported prior authorization delays access to necessary care, 79 percent said patients abandon treatment because of authorization disputes, and more than one in four said prior authorization had led to a serious adverse event including hospitalization, permanent impairment, or death. Only 33 percent of physicians believed the June 2025 insurer pledge to streamline prior authorization would produce meaningful change, and only 24 percent reported that medical necessity denials are consistently reviewed by appropriately qualified clinicians.
How does the 2024 mental health parity final rule affect prior authorization?
The 2024 MHPAEA final rule strengthened requirements for insurers to demonstrate that non-quantitative treatment limitations (including prior authorization) are applied no more restrictively to mental health and substance use disorder benefits than to medical and surgical benefits. The Departments of Labor, HHS, and Treasury issued a non-enforcement statement on May 15, 2025, covering portions of the 2024 rule beyond the 2013 baseline, pending litigation. The 2013 rule and the 2021 CAA NQTL comparative analysis requirement remain in effect. State parity enforcement continues, particularly in Washington, Oregon, West Virginia, and Georgia.
Are SUD treatment authorizations regulated differently than mental health authorizations?
Authorization for substance use disorder treatment is subject to MHPAEA parity requirements, but commercial payers commonly require prior authorization for residential SUD treatment, partial hospitalization, intensive outpatient programs, and medication-assisted treatment delivered in structured programs. Most major commercial payers, including UnitedHealthcare through Optum, use the American Society of Addiction Medicine Criteria, 4th Edition, to evaluate medical necessity. Ten states limit state-regulated commercial plans from imposing prior authorization on SUD services, and five states limit Medicaid’s use of prior authorization for SUD treatment, according to the Partnership to End Addiction. The downstream effect on the SUD industry is the subject of Acuity’s reporting on the in-network migration reshaping the SUD industry.
What should behavioral health providers do to reduce authorization-related revenue loss in 2026?
Industry billing analyses recommend building a real-time payer requirement database rather than relying on annual checklists, documenting to the specific clinical criteria sets payers use (ASAM for SUD, InterQual or MCG for mental health), and using the new CMS-0057-F denial-reason requirements to track which criteria practices most frequently fail to document, then targeting training accordingly. Practices working with covered payers should track payer compliance with the new 7-day and 72-hour decision windows, since payers are now legally accountable for those timelines under federal rule.
